p27 controls Ragulator and mTOR activity in amino acid-deprived cells to regulate the autophagy-lysosomal pathway and coordinate cell cycle and cell growth.


Journal

Nature cell biology
ISSN: 1476-4679
Titre abrégé: Nat Cell Biol
Pays: England
ID NLM: 100890575

Informations de publication

Date de publication:
09 2020
Historique:
received: 09 01 2018
accepted: 06 07 2020
pubmed: 19 8 2020
medline: 31 10 2020
entrez: 19 8 2020
Statut: ppublish

Résumé

Autophagy is a catabolic process whereby cytoplasmic components are degraded within lysosomes, allowing cells to maintain energy homeostasis during nutrient depletion. Several studies reported that the CDK inhibitor p27

Identifiants

pubmed: 32807902
doi: 10.1038/s41556-020-0554-4
pii: 10.1038/s41556-020-0554-4
doi:

Substances chimiques

Amino Acids 0
Proliferating Cell Nuclear Antigen 0
p27 antigen 0
MTOR protein, human EC 2.7.1.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1076-1090

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Références

Neufeld, T. P. & Edgar, B. A. Connections between growth and the cell cycle. Curr. Opin. Cell Biol. 10, 784–790 (1998).
pubmed: 9914170 doi: 10.1016/S0955-0674(98)80122-1
Besson, A., Dowdy, S. F. & Roberts, J. M. CDK inhibitors: cell cycle regulators and beyond. Dev. Cell 14, 159–169 (2008).
pubmed: 18267085 doi: 10.1016/j.devcel.2008.01.013
Chu, I. M., Hengst, L. & Slingerland, J. M. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8, 253–267 (2008).
pubmed: 18354415 doi: 10.1038/nrc2347
Fero, M. L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27
pubmed: 8646781 doi: 10.1016/S0092-8674(00)81239-8
Besson, A. et al. A pathway in quiescent cells that controls p27
pubmed: 16391232 pmcid: 1356100 doi: 10.1101/gad.1384406
Serres, M. et al. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene 30, 2846–2858 (2011).
pubmed: 21317921 doi: 10.1038/onc.2011.9
Besson, A. et al. Discovery of an oncogenic activity in p27
pubmed: 17626791 pmcid: 1920168 doi: 10.1101/gad.1556607
Jeannot, P. et al. p27
Liang, J. et al. The energy sensing LKB1–AMPK pathway regulates p27
pubmed: 17237771 doi: 10.1038/ncb1537
Sharma, S. S. & Pledger, W. J. The non-canonical functions of p27
pubmed: 27082696 pmcid: 4889241 doi: 10.1080/15384101.2016.1157238
Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell. 132, 27–42 (2008).
pubmed: 18191218 pmcid: 2696814 doi: 10.1016/j.cell.2007.12.018
Lorin, S., Hamai, A., Mehrpour, M. & Codogno, P. Autophagy regulation and its role in cancer. Semin. Cancer Biol. 23, 361–379 (2013).
pubmed: 23811268 doi: 10.1016/j.semcancer.2013.06.007
Mizushima, N. & Klionsky, D. J. Protein turnover via autophagy: implications for metabolism. Annu. Rev. Nutr. 27, 19–40 (2007).
pubmed: 17311494 doi: 10.1146/annurev.nutr.27.061406.093749
Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).
pubmed: 28283069 pmcid: 5394987 doi: 10.1016/j.cell.2017.02.004
Sancak, Y. et al. Ragulator–Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290–303 (2010).
pubmed: 20381137 pmcid: 3024592 doi: 10.1016/j.cell.2010.02.024
Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496–1501 (2008).
pubmed: 18497260 pmcid: 2475333 doi: 10.1126/science.1157535
Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P. & Guan, K. L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935–945 (2008).
pubmed: 18604198 pmcid: 2711503 doi: 10.1038/ncb1753
Hosokawa, N. et al. Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981–1991 (2009).
pubmed: 19211835 pmcid: 2663915 doi: 10.1091/mbc.e08-12-1248
Kim, Y. M. et al. mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. Mol. Cell 57, 207–218 (2015).
pubmed: 25533187 doi: 10.1016/j.molcel.2014.11.013
Martina, J. A., Chen, Y., Gucek, M. & Puertollano, R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903–914 (2012).
pubmed: 22576015 pmcid: 3427256 doi: 10.4161/auto.19653
Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429–1433 (2011).
pubmed: 21617040 pmcid: 3638014
Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science 325, 473–477 (2009).
pubmed: 19556463 doi: 10.1126/science.1174447
Yu, L. et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 465, 942–946 (2010).
pubmed: 20526321 pmcid: 2920749 doi: 10.1038/nature09076
Sun, X. et al. p27 protein protects metabolically stressed cardiomyocytes from apoptosis by promoting autophagy. J. Biol. Chem. 289, 16924–16935 (2014).
pubmed: 24794871 pmcid: 4059136 doi: 10.1074/jbc.M113.542795
Su, M. et al. MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ. 22, 986–999 (2014).
pubmed: 25394488 pmcid: 4423182 doi: 10.1038/cdd.2014.187
Short, J. D. et al. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27. Cancer Res. 68, 6496–6506 (2008).
pubmed: 18701472 pmcid: 3011867 doi: 10.1158/0008-5472.CAN-07-5756
Campos, T. et al. Rapamycin requires AMPK activity and p27 expression for promoting autophagy-dependent Tsc2-null cell survival. Biochim. Biophys. Acta 1863, 1200–1207 (2016).
pubmed: 26975583 doi: 10.1016/j.bbamcr.2016.03.009
Short, J. D. et al. AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability. Mol. Carcinog. 49, 429–439 (2010).
pubmed: 20146253 doi: 10.1002/mc.20613
Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1–222 (2016).
pubmed: 26799652 pmcid: 4835977 doi: 10.1080/15548627.2015.1100356
Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132–141 (2011).
pubmed: 21258367 pmcid: 3987946 doi: 10.1038/ncb2152
Nazio, F. et al. Fine-tuning of ULK1 mRNA and protein levels is required for autophagy oscillation. J. Cell Biol. 215, 841–856 (2016).
pubmed: 27932573 pmcid: 5166502 doi: 10.1083/jcb.201605089
Dalle Pezze, P. et al. A systems study reveals concurrent activation of AMPK and mTOR by amino acids. Nat. Commun. 7, 13254 (2016).
pubmed: 27869123 doi: 10.1038/ncomms13254
Song, X. B. et al. Autophagy blockade and lysosomal membrane permeabilization contribute to lead-induced nephrotoxicity in primary rat proximal tubular cells. Cell Death Dis. 8, e2863 (2017).
pubmed: 28594408 pmcid: 5520918 doi: 10.1038/cddis.2017.262
Jager, S. et al. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 117, 4837–4848 (2004).
pubmed: 15340014 doi: 10.1242/jcs.01370
Itakura, E. & Mizushima, N. p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J. Cell Biol. 192, 17–27 (2011).
pubmed: 21220506 pmcid: 3019556 doi: 10.1083/jcb.201009067
Vazquez, C. L. & Colombo, M. I. Assays to assess autophagy induction and fusion of autophagic vacuoles with a degradative compartment, using monodansylcadaverine (MDC) and DQ-BSA. Methods Enzymol. 452, 85–95 (2009).
pubmed: 19200877 doi: 10.1016/S0076-6879(08)03606-9
Turk, V. et al. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta 1824, 68–88 (2012).
pubmed: 22024571 doi: 10.1016/j.bbapap.2011.10.002
Hoshino, D., Tomari, T., Nagano, M., Koshikawa, N. & Seiki, M. A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27
pubmed: 19654316 pmcid: 2785659 doi: 10.1074/jbc.M109.041400
Bar-Peled, L., Schweitzer, L. D., Zoncu, R. & Sabatini, D. M. Ragulator is a GEF for the Rag GTPases that signal amino acid levels to mTORC1. Cell 150, 1196–1208 (2012).
pubmed: 22980980 pmcid: 3517996 doi: 10.1016/j.cell.2012.07.032
Zhang, C. S. et al. The lysosomal v-ATPase–Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20, 526–540 (2014).
pubmed: 25002183 doi: 10.1016/j.cmet.2014.06.014
Shen, K. & Sabatini, D. M. Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms. Proc. Natl Acad. Sci. USA 115, 9545–9550 (2018).
pubmed: 30181260 pmcid: 6156610 doi: 10.1073/pnas.1811727115
Efeyan, A. et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 493, 679–683 (2013).
pubmed: 23263183 doi: 10.1038/nature11745
Soma-Nagae, T. et al. The lysosomal signaling anchor p18/LAMTOR1 controls epidermal development by regulating lysosome-mediated catabolic processes. J. Cell Sci. 126, 3575–3584 (2013).
pubmed: 23781028
de Araujo, M. E. G. et al. Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signaling. Science 358, 377–381 (2017).
pubmed: 28935770 doi: 10.1126/science.aao1583
Su, M. Y. et al. Hybrid structure of the RagA/C–Ragulator mTORC1 activation complex. Mol. Cell 68, 835–846 (2017).
pubmed: 29107538 pmcid: 5722659 doi: 10.1016/j.molcel.2017.10.016
Yonehara, R. et al. Structural basis for the assembly of the Ragulator–Rag GTPase complex. Nat. Commun. 8, 1625 (2017).
pubmed: 29158492 pmcid: 5696360 doi: 10.1038/s41467-017-01762-3
Sun, L. O. et al. Spatiotemporal control of CNS myelination by oligodendrocyte programmed cell death through the TFEB–PUMA axis. Cell 175, 1811–1826 (2018).
pubmed: 30503207 pmcid: 6295215 doi: 10.1016/j.cell.2018.10.044
Chiang, G. G. & Abraham, R. T. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 280, 25485–25490 (2005).
pubmed: 15899889 doi: 10.1074/jbc.M501707200
Hosokawa, N., Hara, Y. & Mizushima, N. Generation of cell lines with tetracycline-regulated autophagy and a role for autophagy in controlling cell size. FEBS Lett. 580, 2623–2629 (2006).
pubmed: 16647067 doi: 10.1016/j.febslet.2006.04.008
Bernfeld, E. et al. Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine. J. Biol. Chem. 293, 16390–16401 (2018).
pubmed: 30194281 pmcid: 6200938 doi: 10.1074/jbc.RA118.004972
Jewell, J. L. et al. Differential regulation of mTORC1 by leucine and glutamine. Science 347, 194–198 (2015).
pubmed: 25567907 pmcid: 4384888 doi: 10.1126/science.1259472
Castedo, M., Ferri, K. F. & Kroemer, G. Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic. Cell Death Differ. 9, 99–100 (2002).
pubmed: 11840159 doi: 10.1038/sj.cdd.4400978
Hung, C. M., Garcia-Haro, L., Sparks, C. A. & Guertin, D. A. mTOR-dependent cell survival mechanisms. Cold Spring Harb. Perspect. Biol. 4, a008771 (2012).
Nourse, J. et al. Interleukin-2-mediated elimination of the p27
pubmed: 7990932 doi: 10.1038/372570a0
Luo, Y. et al. Rapamycin resistance tied to defective regulation of p27
pubmed: 8943329 pmcid: 231677 doi: 10.1128/MCB.16.12.6744
Dalvai, M., Schubart, K., Besson, A. & Matthias, P. Oct1 is required for mTOR-induced G
pubmed: 20935455 doi: 10.4161/cc.9.19.13154
Cuyas, E., Corominas-Faja, B., Joven, J. & Menendez, J. A. Cell cycle regulation by the nutrient-sensing mammalian target of rapamycin (mTOR) pathway. Methods Mol. Biol. 1170, 113–144 (2014).
pubmed: 24906312 doi: 10.1007/978-1-4939-0888-2_7
Hong, F. et al. mTOR–Raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol. Cell 30, 701–711 (2008).
pubmed: 18570873 doi: 10.1016/j.molcel.2008.04.027
Aguilar, V. & Fajas, L. Cycling through metabolism. EMBO Mol. Med. 2, 338–348 (2010).
pubmed: 20721988 pmcid: 3118222 doi: 10.1002/emmm.201000089
Lopez-Mejia, I. C., Castillo-Armengol, J., Lagarrigue, S. & Fajas, L. Role of cell cycle regulators in adipose tissue and whole body energy homeostasis. Cell. Mol. Life Sci. 75, 975–987 (2017).
pubmed: 28988292 doi: 10.1007/s00018-017-2668-9
Fuster, J. J. et al. Tumor suppressor p27
pubmed: 20228253 doi: 10.1096/fj.09-138255
Jia, W. et al. Autophagy regulates T lymphocyte proliferation through selective degradation of the cell-cycle inhibitor CDKN1B/p27Kip1. Autophagy 11, 2335–2345 (2015).
pubmed: 26569626 pmcid: 4835188 doi: 10.1080/15548627.2015.1110666
Zhou, J. et al. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome–lysosome fusion. Cell Res. 23, 508–523 (2013).
pubmed: 23337583 pmcid: 3616426 doi: 10.1038/cr.2013.11
Pena-Llopis, S. et al. Regulation of TFEB and v-ATPases by mTORC1. EMBO J. 30, 3242–3258 (2011).
pubmed: 21804531 pmcid: 3160667 doi: 10.1038/emboj.2011.257
Lawrence, R. E. et al. A nutrient-induced affinity switch controls mTORC1 activation by its Rag GTPase–Ragulator lysosomal scaffold. Nat. Cell Biol. 20, 1052–1063 (2018).
pubmed: 30061680 pmcid: 6279252 doi: 10.1038/s41556-018-0148-6
Villegas, F. et al. Lysosomal signaling licenses embryonic stem cell differentiation via inactivation of Tfe3. Cell Stem Cell 24, 257–270 (2019).
pubmed: 30595499 doi: 10.1016/j.stem.2018.11.021
Harada, H., Andersen, J. S., Mann, M., Terada, N. & Korsmeyer, S. J. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc. Natl Acad. Sci. USA 98, 9666–9670 (2001).
pubmed: 11493700 pmcid: 55509 doi: 10.1073/pnas.171301998
Chen, G. et al. Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer. J. Mol. Med. 88, 941–952 (2010).
pubmed: 20508912 doi: 10.1007/s00109-010-0635-0
Besson, A., Gurian-West, M., Schmidt, A., Hall, A. & Roberts, J. M. p27
pubmed: 15078817 pmcid: 395846 doi: 10.1101/gad.1185504
Serres, M. P. et al. p27
pubmed: 22293177 pmcid: 3287231 doi: 10.1172/JCI60376
N’Diaye, E. N. et al. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 10, 173–179 (2009).
pubmed: 19148225 pmcid: 2637314 doi: 10.1038/embor.2008.238
Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296–1302 (2004).
pubmed: 15268862 doi: 10.1016/j.cub.2004.06.054
Spector, D. L. in Cells: A Laboratory Manual, Vol. 1. (eds Spector, D. L., Goldman R. D. & Leinwand L. A.) 4.3–4.7 (Cold Spring Harbor Laboratory Press, 1997).

Auteurs

Ada Nowosad (A)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.
UCL Cancer Institute, University College London, London, UK.

Pauline Jeannot (P)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Caroline Callot (C)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Justine Creff (J)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Renaud Thierry Perchey (RT)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Carine Joffre (C)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Patrice Codogno (P)

Institut Necker-Enfants Malades (INEM), INSERM U1151, CNRS UMR 8253, Paris, France.
Université Paris Descartes-Sorbonne Paris Cité, Paris, France.

Stephane Manenti (S)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Arnaud Besson (A)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France. arnaud.besson@univ-tlse3.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH